Macrae Sandy
Sangamo Therapeutics, Inc. · PRESIDENT
Macrae Sandy is listed in filings as PRESIDENT at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including 20 public disclosures. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO). The current snapshot covers public activity from Aug 27, 2024 to May 27, 2026. Reported amounts are shown as $2.2K to $15.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||